These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 19014684

  • 1. Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola.
    Figueiredo P, Benchimol C, Lopes D, Bernardino L, do Rosário VE, Varandas L, Nogueira F.
    Malar J; 2008 Nov 17; 7():236. PubMed ID: 19014684
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.
    Ghanchi NK, Ursing J, Beg MA, Veiga MI, Jafri S, Mårtensson A.
    Malar J; 2011 Jan 28; 10():18. PubMed ID: 21272384
    [Abstract] [Full Text] [Related]

  • 3. Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea).
    Berzosa P, Esteban-Cantos A, García L, González V, Navarro M, Fernández T, Romay-Barja M, Herrador Z, Rubio JM, Ncogo P, Santana-Morales M, Valladares B, Riloha M, Benito A.
    Malar J; 2017 Jan 13; 16(1):28. PubMed ID: 28086777
    [Abstract] [Full Text] [Related]

  • 4. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
    Madkhali AM, Al-Mekhlafi HM, Atroosh WM, Ghzwani AH, Zain KA, Abdulhaq AA, Ghailan KY, Anwar AA, Eisa ZM.
    Malar J; 2020 Dec 02; 19(1):446. PubMed ID: 33267841
    [Abstract] [Full Text] [Related]

  • 5. Comparative assessment on the prevalence of mutations in the Plasmodium falciparum drug-resistant genes in two different ecotypes of Odisha state, India.
    Kar NP, Chauhan K, Nanda N, Kumar A, Carlton JM, Das A.
    Infect Genet Evol; 2016 Jul 02; 41():47-55. PubMed ID: 26988711
    [Abstract] [Full Text] [Related]

  • 6. Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
    Enosse S, Magnussen P, Abacassamo F, Gómez-Olivé X, Rønn AM, Thompson R, Alifrangis M.
    Malar J; 2008 Jul 01; 7():115. PubMed ID: 18590577
    [Abstract] [Full Text] [Related]

  • 7. Molecular Surveillance of Drug Resistance of Plasmodium falciparum Isolates Imported from Angola in Henan Province, China.
    Zhou R, Yang C, Li S, Zhao Y, Liu Y, Qian D, Wang H, Lu D, Zhang H, Huang F.
    Antimicrob Agents Chemother; 2019 Oct 01; 63(10):. PubMed ID: 31358591
    [Abstract] [Full Text] [Related]

  • 8. Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genes.
    Sitali L, Mwenda MC, Miller JM, Bridges DJ, Hawela MB, Hamainza B, Mudenda-Chilufya M, Chizema-Kawesha E, Daniels RF, Eisele TP, Nerland AH, Chipeta J, Lindtjorn B.
    Acta Trop; 2020 Dec 01; 212():105704. PubMed ID: 33002448
    [Abstract] [Full Text] [Related]

  • 9. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
    Schönfeld M, Barreto Miranda I, Schunk M, Maduhu I, Maboko L, Hoelscher M, Berens-Riha N, Kitua A, Löscher T.
    Malar J; 2007 Jan 15; 6():2. PubMed ID: 17224049
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran.
    Zakeri S, Afsharpad M, Raeisi A, Djadid ND.
    Malar J; 2007 Nov 13; 6():148. PubMed ID: 17999755
    [Abstract] [Full Text] [Related]

  • 11. Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.
    Spalding MD, Eyase FL, Akala HM, Bedno SA, Prigge ST, Coldren RL, Moss WJ, Waters NC.
    Malar J; 2010 Nov 24; 9():338. PubMed ID: 21106088
    [Abstract] [Full Text] [Related]

  • 12. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N.
    Acta Trop; 2016 Dec 24; 164():329-336. PubMed ID: 27647575
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of prevalence's of pfdhfr and pfdhps mutations in Angola.
    Fortes F, Dimbu R, Figueiredo P, Neto Z, do Rosário VE, Lopes D.
    Malar J; 2011 Feb 02; 10():22. PubMed ID: 21288345
    [Abstract] [Full Text] [Related]

  • 14. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
    Alareqi LMQ, Mahdy MAK, Lau YL, Fong MY, Abdul-Ghani R, Mahmud R.
    Acta Trop; 2016 Oct 02; 162():174-179. PubMed ID: 27343362
    [Abstract] [Full Text] [Related]

  • 15. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum.
    Osman ME, Mockenhaupt FP, Bienzle U, Elbashir MI, Giha HA.
    Infect Genet Evol; 2007 Jan 02; 7(1):52-9. PubMed ID: 16690361
    [Abstract] [Full Text] [Related]

  • 16. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
    Kaingona-Daniel EP, Gomes LR, Gama BE, Almeida-de-Oliveira NK, Fortes F, Ménard D, Daniel-Ribeiro CT, Ferreira-da-Cruz Mde F.
    Malar J; 2016 Jun 07; 15():309. PubMed ID: 27267365
    [Abstract] [Full Text] [Related]

  • 17. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.
    Rana R, Khan N, Sandeepta S, Pati S, Das A, Bal M, Ranjit M.
    Malar J; 2022 Dec 24; 21(1):394. PubMed ID: 36566182
    [Abstract] [Full Text] [Related]

  • 18. A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan.
    Khattak AA, Venkatesan M, Jacob CG, Artimovich EM, Nadeem MF, Nighat F, Hombhanje F, Mita T, Malik SA, Plowe CV.
    Malar J; 2013 Aug 29; 12():300. PubMed ID: 23988011
    [Abstract] [Full Text] [Related]

  • 19. Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications.
    Mubjer RA, Adeel AA, Chance ML, Hassan AA.
    Malar J; 2011 Aug 21; 10():245. PubMed ID: 21854642
    [Abstract] [Full Text] [Related]

  • 20. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
    Bamaga OA, Mahdy MA, Lim YA.
    Malar J; 2015 Dec 22; 14():516. PubMed ID: 26693691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.